by smcork | Oct 11, 2012 | Commentary
When the Supreme Court upheld the constitutionality of the Patient Protection and Affordable Care Act on June 28, the impact was diverse and widespread. Relief was felt in one corner of the pharmaceutical industry, however, as the decision protected continued...
by rapincb | Sep 30, 2010 | Commentary
In an amicus brief filed on Wednesday, September 8th, 2010 in support of Eli Lilly & Company’s (“Lilly”) petition for an en banc hearing of Sun Pharm. Indus., Ltd. v. Eli Lilly & Co., trade organization Biotechnology Industry Organization (“BIO”) alleged that...
by anickow | Sep 29, 2008 | Uncategorized
by: Stephen Moyer, Associate Editor, MTTLRIntroduction Image Biotic lensbaby by Sparky.Used under a Creative Commons BY-NC 2.0 license.The contributions of research universities to worldwide scientific progress have traditionally been focused on basic scientific...
